OpenAlex | Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

Work

Year: 2000

Type: article

Source: European Journal of Clinical Pharmacology

Authors Marleen Depré, Elliot Ehrich, Anne Van Hecken, Inge De Lepeleire, A. Dallob +4 more

Institutions KU Leuven, Merck & Co., Inc., Rahway, NJ, USA (United States)

Cites: 18

Cited by: 98

Related to: 10

FWCI: 9.408

Citation percentile (by year/subfield): 80.38

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal Good health and well-being

Open Access status: closed